HMS Capital Management LLC Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

HMS Capital Management LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,629 shares of the healthcare conglomerate’s stock after selling 62 shares during the period. UnitedHealth Group comprises 0.9% of HMS Capital Management LLC’s holdings, making the stock its 29th biggest position. HMS Capital Management LLC’s holdings in UnitedHealth Group were worth $1,836,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Genesee Capital Advisors LLC increased its holdings in UnitedHealth Group by 1.9% in the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after purchasing an additional 18 shares during the last quarter. Jmac Enterprises LLC grew its holdings in shares of UnitedHealth Group by 2.2% during the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after buying an additional 18 shares in the last quarter. Powers Advisory Group LLC boosted its position in UnitedHealth Group by 4.8% during the third quarter. Powers Advisory Group LLC now owns 418 shares of the healthcare conglomerate’s stock valued at $244,000 after purchasing an additional 19 shares during the last quarter. Wallace Capital Management Inc. boosted its position in UnitedHealth Group by 0.9% during the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock valued at $1,239,000 after purchasing an additional 19 shares during the last quarter. Finally, Western Pacific Wealth Management LP lifted its position in shares of UnitedHealth Group by 2.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after buying an additional 19 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

Several analysts recently weighed in on UNH shares. Barclays dropped their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. TD Cowen upped their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Stephens upped their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $527.31 on Thursday. The firm has a market cap of $485.27 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The firm’s 50 day simple moving average is $526.25 and its 200-day simple moving average is $563.96. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm posted $5.83 earnings per share. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.